-
-
-
-
-
-
-
Oppenheimer Upgrades Capricor Therapeutics (CAPR) to Outperform 'on Approval Optimism'
-
-
-
-
-
-
-
Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
-
-
-
-
-
-
-
Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
-
-
-
-
-
-
-
Oppenheimer Downgrades Capricor Therapeutics (CAPR) to Perform
-
-
-
-
-
-
-
Alliance Global Partners Downgrades Capricor Therapeutics (CAPR) to Neutral
-
-
-
-
-
-
-
Oppenheimer Reiterates Capricor Therapeutics (CAPR) at Outperform, 'like the risk-reward'
-
-
-
-
-
-
-
Capricor sues NS Pharma over Duchenne therapy distribution deal
-
460,591 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

